相关实验视频
Updated: Jan 15, 2026

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
28.5K
患有较高恶化负担和埃索因菲尔计数的患者更有可能需要多种生物药物来控制喘
Alyson N Brown1, Tanawin Nopsopon1,2, Ayobami Akenroye1,2,3
1Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Journal of asthma and allergy
|October 13, 2025
概括
患有严重喘的患者转换生物药物往往是由于不理想的反应. 较高的恶化率和血中乙氨基酸细胞数量预测了严重喘管理中的生物切换.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于严重的喘,有多种生物疗法可用,使得治疗可以切换.
- 确定生物切换的预测因素对于优化严重喘管理至关重要.
研究的目的:
- 为了确定转换生物疗法的严重喘患者的特征.
- 了解中度至重度喘中生物转换的主要原因.
主要方法:
- 对1611名中度至重度喘患者进行了回顾性图表审查,开始进行生物疗法.
- 分析与转换生物药物相关的因素,包括恶化率和血中乙氨基酸细胞计数.
- 在非切换者,单切换者和多切换者之间比较患者特征.
主要成果:
- 14%的患者转换了生物药物,而低于最佳的反应是主要原因 (>70%).
- 较高的启动前恶化率和最大血中乙氨基酸细胞数量与更换的可能性增加有关.
- 在治疗的第一年,非切换者的恶化显著下降,但在切换者中没有显著下降.
结论:
- 患有更严重喘的患者,由更高的恶化率和氨酸细胞数量表明,更容易切换生物药物.
- 仔细选择最初的生物疗法和优化治疗时间对于有效的严重喘管理至关重要.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
726
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
726
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K

